Particle.news

Download on the App Store

Citron’s Andrew Left Raises Short Bet on Palantir, Dubbing Valuation 'Absurd'

Left boosted his bearish position following Palantir’s blockbuster second-quarter results to spotlight what he calls an unsupportable price-to-earnings and price-to-sales ratio.

Image
FILE PHOTO: Andrew Left, the founder of Citron Research, speaks during the Reuters Global Investment 2019 Outlook Summit, in New York

Overview

  • Citron founder Andrew Left told Fox Business that he is shorting Palantir and added to his position after the company’s Q2 earnings release.
  • Palantir notched its first $1 billion revenue quarter and pushed closed total contract value to a record $2.27 billion, topping Wall Street estimates.
  • Left characterized the stock’s multiples as “absurd,” citing roughly an 80x price-to-sales ratio and a 290x forward price-to-earnings ratio.
  • The shares have climbed about 144 percent this year and maintain strong momentum driven by a large retail following that could amplify short-squeeze risk.
  • Left’s reputation is contested due to past high-profile short campaigns and ongoing legal actions alleging market manipulation and securities fraud.